News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,313 Results
Type
Article (47341)
Company Profile (460)
Press Release (691512)
Section
Business (216973)
Career Advice (2360)
Deals (36990)
Drug Delivery (105)
Drug Development (84981)
Employer Resources (179)
FDA (16855)
Job Trends (15660)
News (364736)
Policy (34128)
Tag
Academia (2821)
Alliances (53096)
Alzheimer's disease (1396)
Approvals (16820)
Artificial intelligence (223)
Bankruptcy (371)
Best Places to Work (12282)
Biotechnology (338)
Breast cancer (237)
Cancer (1793)
Cardiovascular disease (142)
Career advice (1968)
CAR-T (128)
Cell therapy (377)
Clinical research (68153)
Collaboration (715)
Compensation (376)
COVID-19 (2692)
C-suite (174)
Data (1668)
Diabetes (223)
Diagnostics (6670)
Earnings (88836)
Employer resources (157)
Events (119571)
Executive appointments (598)
FDA (17792)
Funding (642)
Gene therapy (270)
GLP-1 (719)
Government (4590)
Healthcare (20114)
Infectious disease (2808)
Inflammatory bowel disease (132)
Interviews (382)
IPO (17044)
Job creations (3860)
Job search strategy (1679)
Layoffs (483)
Legal (8231)
Lung cancer (264)
Manufacturing (250)
Medical device (13976)
Medtech (13981)
Mergers & acquisitions (20323)
Metabolic disorders (598)
Neuroscience (1833)
NextGen: Class of 2025 (7172)
Non-profit (4854)
Northern California (2140)
Obesity (335)
Opinion (231)
Patents (165)
People (61336)
Phase I (21392)
Phase II (30061)
Phase III (22233)
Pipeline (734)
Postmarket research (2669)
Preclinical (9168)
Radiopharmaceuticals (260)
Rare diseases (351)
Real estate (6359)
Regulatory (23117)
Research institute (2558)
Resumes & cover letters (390)
Southern California (1841)
Startups (3865)
United States (19338)
Vaccines (663)
Weight loss (241)
Date
Today (11)
Last 7 days (623)
Last 30 days (2638)
Last 365 days (36151)
2025 (4681)
2024 (37016)
2023 (41875)
2022 (53244)
2021 (57875)
2020 (56479)
2019 (49662)
2018 (37554)
2017 (34348)
2016 (33959)
2015 (40175)
2014 (33837)
2013 (28950)
2012 (31128)
2011 (31649)
2010 (29690)
Location
Africa (812)
Arizona (231)
Asia (41309)
Australia (6962)
California (4944)
Canada (1743)
China (408)
Colorado (223)
Connecticut (249)
Europe (91886)
Florida (698)
Georgia (176)
Illinois (499)
Indiana (268)
Maryland (769)
Massachusetts (3823)
Michigan (220)
Minnesota (350)
New Jersey (1395)
New York (1403)
North Carolina (928)
Northern California (2140)
Ohio (182)
Pennsylvania (1121)
South America (1226)
Southern California (1841)
Texas (731)
Utah (149)
Washington State (495)
739,313 Results for "lead therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236
CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced it successfully executed pre-IND manufacturing activities for its lead therapeutic, CER-1236.
June 13, 2024
·
4 min read
Press Releases
ONL Therapeutics Announces Multiple Presentations at Leading Ophthalmology Meetings
February 4, 2025
·
3 min read
Press Releases
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
·
5 min read
Press Releases
Secretome Therapeutics, Inc. Announces Composition of Matter Patents for Lead Assets STM-01 and STM-21
October 28, 2024
·
2 min read
Weight loss
BioAge Drops Lead Obesity Asset Months After IPO
It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after the molecule caused liver-based side effects.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)
February 21, 2025
·
6 min read
Obesity
Obesity-Focused Aardvark Therapeutics Files IPO to Advance Lead Candidate
The San Diego–based company’s molecules avoid the well-trod GLP-1 pathway in favor of an alternate route in the gut.
January 24, 2025
·
1 min read
·
Dan Samorodnitsky
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) Announces Launch to Set New Standard in Life Sciences Commercialization Management Consulting
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) is proud to announce its official launch, poised to set a new standard in life sciences consulting.
April 30, 2024
·
3 min read
Press Releases
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial
February 6, 2025
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 73,932
Next
